Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach

scientific article

Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CARCIN/BGQ113
P932PMC publication ID2915632
P698PubMed publication ID20547493
P5875ResearchGate publication ID44672688

P50authorLoic Le MarchandQ28360612
Veronica Wendy SetiawanQ28805341
Christopher A. HaimanQ73606228
Brian E. HendersonQ73660621
Giske UrsinQ46387795
Leslie BernsteinQ60607806
David Van Den BergQ60686183
Pamela L Horn-RossQ60716556
Pedram RazaviQ63869181
P2093author name stringEunjung Lee
Chris Hsu
P2860cites workA functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer riskQ24535819
The structure of haplotype blocks in the human genomeQ27860500
Haploview: analysis and visualization of LD and haplotype mapsQ27860955
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid populationQ29614401
Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort StudyQ30815307
Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.Q31149715
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoformQ74281193
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesteroneQ77636062
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer developmentQ79753736
Long-term postmenopausal hormone therapy and endometrial cancerQ33650188
Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavonesQ34491637
No association between progesterone receptor gene +331G/A polymorphism and endometrial cancerQ34546683
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic reviewQ35032177
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristicsQ35786223
Reproductive tissue selective actions of progesterone receptors.Q35848877
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 casesQ35857243
A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma.Q36080535
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer riskQ36465880
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisQ36614790
Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE reviewQ36655780
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer ConsortiumQ37157438
Endometrioid carcinoma of the ovary: retrospective review of 145 casesQ38009676
Estrogen-progestin replacement therapy and endometrial cancerQ38504098
Progestins and menopause: epidemiological studies of risks of endometrial and breast cancerQ39553740
High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).Q40631500
No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.Q43007578
Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patientsQ43773489
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaQ44082612
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic CohortQ44307819
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenQ44472863
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.Q45173699
Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysisQ45211865
Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinomaQ45279423
Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancerQ46667600
Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancerQ46855999
Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertionQ48072384
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone.Q51799857
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.Q52930435
Endometrial cancerQ63199203
Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometriaQ71100414
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectgenetic variationQ349856
endometrial cancerQ944777
P304page(s)1392-1399
P577publication date2010-06-13
P1433published inCarcinogenesisQ326022
P1476titleGenetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach
P478volume31

Reverse relations

cites work (P2860)
Q37691657An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors
Q34562166Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis
Q37260827Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women
Q44636781Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis.
Q34096825Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia
Q39373892Gene x environment interactions impact endometrial function and the menstrual cycle: PROGINS, life history, anthropometry, and physical activity
Q28260010Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats
Q91583952Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection
Q35018327Progesterone receptor gene variants and risk of endometrial cancer
Q55297932Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
Q33809605The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
Q47246925Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers

Search more.